...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Researchers Successfully Treat Metastatic Cancer

Hello everyone, 

It has been a long while since I have posted but I sure have enjoyed all the wonderful bits of information you all contribute... selfish of me!     I have been here too long waiting for the chips to fall and I am more optimistic now than ever.    

In any event, I came across 2 similar articles (from Oct 18) about Zen-3694 that I have not read about on Agoracom.  Maybe I missed it!

https://www.technology.org/2018/10/18/researchers-successfully-treat-metastatic-cancer-using-an-ai-algorithm/

https://www.futurity.org/artificial-intelligence-cancer-drugs-1890362/

I hope you find it interesting.

Long

 

 

Share
New Message
Please login to post a reply